Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis
Open Access
- 1 April 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 16 (4) , 615-624
Abstract
Immunization with heat‐shock protein (HSP) gp96 elicits protective immunity to the cancer or virus‐infected cells from which it is derived. Low doses of gp96 generate immunity, while doses 10 times the immunizing dose do not. We show here that injection of high doses of gp96 generates CD4+ T cells that down‐regulate a variety of ongoing immune responses. Immunization with high doses of gp96 prevents myelin basic protein‐ or proteolipid protein‐induced autoimmune encephalomyelitis in SJL mice and the onset of diabetes in non‐obese diabetic mice. The suppression of immune response can be adoptively transferred with CD4+ cells and does not partition with the CD25 phenotype. The immunomodulatory properties of gp96 (and possibly other HSP) may be used for antigen‐specific activation or suppression of cellular immune responses. The latter may form the basis for novel immunotherapies for autoimmune diseases.Keywords
This publication has 31 references indexed in Scilit:
- Heat Shock Proteins as Ligands of Toll-Like Receptors2002
- CD91 Is a Common Receptor for Heat Shock Proteins gp96, hsp90, hsp70, and CalreticulinImmunity, 2001
- Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: A pilot studyInternational Journal of Cancer, 2000
- B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune DiabetesImmunity, 2000
- Activation of cytotoxic T cells in vitro by recombinant gp96 fusion proteins irrespective of the 'fused' antigenic peptide sequenceImmunology Letters, 1999
- Isolation of processed, H-2Kb -binding ovalbumin-derived peptides associated with the stress proteins HSP70 and GP96European Journal of Immunology, 1998
- The NOD Mouse: A Model for Insulin‐Dependent Diabetes MellitusCurrent Protocols in Immunology, 1997
- Minireview: Autoimmune responses to myelin proteolipid proteinNeurochemical Research, 1994
- T cells bearing the CD44hi “memory” phenotype display characteristics of activated cells in G1 stage of cell cycleCellular Immunology, 1992
- The serologically unique cell surface antigen of zajdela ascitic hepatoma is also its tumor‐associated transplantation antigenInternational Journal of Cancer, 1984